US › Healthcare

60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)

US · Healthcare · Biotechnology

$1.23+6.03%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$162,092
Revenue YoY
-0.9%
Net profit
$-2.1M
Profit YoY
-11.4%
EPS
$-1.21
EPS estimate
$-0.99
Net margin
-1,289.5%

EPS came in at -1.21 against a street estimate of -0.99 — a miss of 22.6%.

Key statistics

Market cap
$3.1M
Forward P/E
0.0
P/B
0.00
Book value
$-1.80
EPS (TTM)
$-6.76
52-week high
$7.36
52-week low
$1.05
50-day MA
$1.52
200-day MA
$2.74
Beta
2.54

Analyst view

Analysts rate 60 Degrees Pharmaceuticals, Inc. Common Stock a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $3.70.

Shareholding

Insiders
25.65%
Institutions
14.69%

Largest institutional holders

FundStake
Kathmere Capital Management, LLC9.97%
UBS Group AG1.18%
Geode Capital Management, LLC0.61%
Barclays PLC0.07%
Goss Wealth Management LLC0.00%
Advisor Group Holdings, Inc.0.00%
TWIN PEAKS WEALTH ADVISORS LLC0.00%
Citigroup Inc0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for 60 Degrees Pharmaceuticals, Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.